Research Article|Articles in Press

Radical versus partial nephrectomy for T1 non-clear cell renal cell carcinoma

Published:March 16, 2023DOI:



      Nephron-sparing surgery is the recommended surgical management of T1 renal cell carcinoma (RCC). However, non-clear cell RCC (nccRCC) is heterogeneous and included many histological types. Therefore, the present study was performed to compare radical nephrectomy (RN) versus partial nephrectomy (PN) in nccRCC.

      Materials and methods

      Within the Surveillance, Epidemiology, and End Results registry (2000–2019), the patients with nccRCC were identified. Kaplan-Meier survival curve and the log-rank test were conducted. Univariate analysis and multivariate Cox regression analysis were performed to explore the prognostic factors.


      A total of 7575 patients with nccRCC were included, of which papillary RCC (n = 5219) is the major histology. Kaplan-Meier plots and log-rank tests showed that nccRCC patients who underwent RN had significantly worse overall survival (OS) and cancer-specific survival (CSS) than those who received PN (all P < 0.05). Multivariate analysis also revealed that RN was significantly associated with poor OS and CSS in nccRCC patients. Stratified by histological types, the multivariate analysis also revealed that RN was significantly associated with poor OS in papillary and chromophobe (all P < 0.05). Besides, the multivariable analysis indicated that RN was associated with poor CSS in papillary RCC (P < 0.05). For other histology, the patients who received RN had a comparable survival to those who received PN.


      For patients with T1 nccRCC, our findings revealed that PN was not inferior to RN in OS and CSS. PN may be also the preferred option for T1 nccRCC, but more prospective studies are required to validate this finding.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to European Journal of Surgical Oncology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Sung H.
        • Ferlay J.
        • Siegel R.L.
        • et al.
        Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.
        CA A Cancer J Clin. 2021; 71: 209
        • MacLennan S.
        • Imamura M.
        • Lapitan M.C.
        • et al.
        Systematic review of perioperative and quality-of-life outcomes following surgical management of localised renal cancer.
        Eur Urol. 2012; 62: 1097
        • Van Poppel H.
        • Da Pozzo L.
        • Albrecht W.
        • et al.
        A prospective, randomised EORTC intergroup phase 3 study comparing the oncologic outcome of elective nephron-sparing surgery and radical nephrectomy for low-stage renal cell carcinoma.
        Eur Urol. 2011; 59: 543
        • Scosyrev E.
        • Messing E.M.
        • Sylvester R.
        • et al.
        Renal function after nephron-sparing surgery versus radical nephrectomy: results from EORTC randomized trial 30904.
        Eur Urol. 2014; 65: 372
        • Ljungberg B.
        • Albiges L.
        • Abu-Ghanem Y.
        • et al.
        European association of urology guidelines on renal cell carcinoma: the 2022 update.
        Eur Urol. 2022; 82: 399
        • Gershman B.
        • Thompson R.H.
        • Boorjian S.A.
        • et al.
        Radical versus partial nephrectomy for cT1 renal cell carcinoma.
        Eur Urol. 2018; 74: 825
        • Park H.S.
        • Lloyd S.
        • Decker R.H.
        • et al.
        Overview of the Surveillance, Epidemiology, and End Results database: evolution, data variables, and quality assurance.
        Curr Probl Cancer. 2012; 36: 183
        • Capitanio U.
        • Terrone C.
        • Antonelli A.
        • et al.
        Nephron-sparing techniques independently decrease the risk of cardiovascular events relative to radical nephrectomy in patients with a T1a-T1b renal mass and normal preoperative renal function.
        Eur Urol. 2015; 67: 683
        • Kates M.
        • Badalato G.M.
        • Pitman M.
        • et al.
        Increased risk of overall and cardiovascular mortality after radical nephrectomy for renal cell carcinoma 2 cm or less.
        J Urol. 2011; 186: 1247
        • Huang W.C.
        • Elkin E.B.
        • Levey A.S.
        • et al.
        Partial nephrectomy versus radical nephrectomy in patients with small renal tumors--is there a difference in mortality and cardiovascular outcomes?.
        J Urol. 2009; 181: 55
        • MacLennan S.
        • Imamura M.
        • Lapitan M.C.
        • et al.
        Systematic review of oncological outcomes following surgical management of localised renal cancer.
        Eur Urol. 2012; 61: 972
        • Yang F.
        • Zhou Q.
        • Xing N.
        Comparison of survival and renal function between partial and radical laparoscopic nephrectomy for T1b renal cell carcinoma.
        J Cancer Res Clin Oncol. 2020; 146: 261
        • Mir M.C.
        • Derweesh I.
        • Porpiglia F.
        • et al.
        Partial nephrectomy versus radical nephrectomy for clinical T1b and T2 renal tumors: a systematic review and meta-analysis of comparative studies.
        Eur Urol. 2017; 71: 606
        • Bigot P.
        • Bernhard J.C.
        • Gill I.S.
        • et al.
        The subclassification of papillary renal cell carcinoma does not affect oncological outcomes after nephron sparing surgery.
        World J Urol. 2016; 34: 347
        • Steward J.E.
        • Kern S.Q.
        • Cheng L.
        • et al.
        Clear cell papillary renal cell carcinoma: characteristics and survival outcomes from a large single institutional series.
        Urol Oncol. 2021; 39: 370.e21
        • Przybycin C.G.
        • Harper H.L.
        • Reynolds J.P.
        • et al.
        Acquired cystic disease-associated renal cell carcinoma (ACD-RCC): a multiinstitutional study of 40 cases with clinical follow-up.
        Am J Surg Pathol. 2018; 42: 1156
        • Amin M.B.
        • MacLennan G.T.
        • Gupta R.
        • et al.
        Tubulocystic carcinoma of the kidney: clinicopathologic analysis of 31 cases of a distinctive rare subtype of renal cell carcinoma.
        Am J Surg Pathol. 2009; 33: 384
        • Trpkov K.
        • Hes O.
        • Williamson S.R.
        • et al.
        New developments in existing WHO entities and evolving molecular concepts: the Genitourinary Pathology Society (GUPS) update on renal neoplasia.
        Mod Pathol. 2021; 34: 1392